Erratum: Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria

被引：0
|
作者：
Russell P Rother
Scott A Rollins
Christopher F Mojcik
Robert A Brodsky
Leonard Bell
机构：
来源：
Nature Biotechnology | 2007年 / 25卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Nat. Biotechnol. 25, 1256–1264 (2007); published online 7 November 2007; corrected after print 7 December 2007 In the version of this article initially published, on p. 1258, paragraph 2, the incorrect serum concentrations to reach steady state and the incorrect accumulation ratio (Racc) for eculizumab were given.
引用
收藏
页码：1488 / 1488
相关论文
共 50 条
  • [41] Eculizumab: A novel therapy for paroxysmal nocturnal hemoglobinuria
    Zareba, Karolina M.
    DRUGS OF TODAY, 2007, 43 (08) : 539 - 546
  • [42] Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
    Hillmen, Peter
    Szer, Jeff
    Weitz, Ilene
    Roeth, Alexander
    Hoechsmann, Britta
    Panse, Jens
    Usuki, Kensuke
    Griffin, Morag
    Kiladjian, Jean-Jacques
    de Castro, Carlos
    Nishimori, Hisakazu
    Tan, Lisa
    Hamdani, Mohamed
    Deschatelets, Pascal
    Francois, Cedric
    Grossi, Federico
    Ajayi, Temitayo
    Risitano, Antonio
    de la Tour, Regis Peffault
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (11): : 1028 - 1037
  • [43] Terminal Complement Inhibitor Eculizumab Improves Complement-Mediated Platelet Consumption and Thrombocytopenia in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)
    Socie, Gerard
    Muus, Petra
    Schrezenmeier, Hubert
    Hoechsmann, Britta
    Maciejewski, Jaroslaw P.
    Weitz, Ilene Ceil
    Hill, Anita
    Bessler, Monica
    Risitano, Antonio M.
    BLOOD, 2009, 114 (22) : 1546 - 1547
  • [44] Terminal complement inhibitor eculizumab improves complement-mediated platelet consumption and thrombocytopenia in patients with paroxysmal nocturnal hemoglobinuria (PNH)
    Hill, A.
    Socie, G.
    Muus, P.
    Schrezenmeier, H.
    Hochsmann, B.
    Maciejewski, J.
    Weitz, I. C.
    Bessler, M.
    Risitano, A. M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 : 10 - 10
  • [45] Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria: the AEGIS Clinical Trial
    Kanakura, Yuzuru
    Ohyashiki, Kazuma
    Shichishima, Tsutomu
    Okamoto, Shinichiro
    Ando, Kiyoshi
    Ninomiya, Haruhiko
    Kawaguchi, Tatsuya
    Nakao, Shinji
    Nakakuma, Hideki
    Nishimura, Jun-ichi
    Kinoshita, Taroh
    Bedrosian, Camille L.
    Valentine, Marye Ellen
    Khursigara, Gus
    Ozawa, Keiya
    Omine, Mitsuhiro
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 93 (01) : 36 - 46
  • [46] Expanding Complement Therapeutics for the Treatment of Paroxysmal Nocturnal Hemoglobinuria
    Mastellos, Dimitrios C.
    Reis, Edimara S.
    Yancopoulou, Despina
    Risitano, Antonio M.
    Lambris, John D.
    SEMINARS IN HEMATOLOGY, 2018, 55 (03) : 167 - 175
  • [47] Treatment with the terminal complement inhibitor eculizumab improves anemia in patients with paroxysmal nocturnal hemoglobinuria:: Phase III triumph study results.
    Schubert, Joerg
    Hillmen, Peter
    Duehrsen, Ulrich
    Young, Neal S.
    Elebute, Modupe
    Szer, Jeffrey
    Gianfaldoni, Giacomo
    Socie, Gerard
    Browne, Paul
    Mojcik, Christopher F.
    Rother, Russell P.
    Muus, Petra
    BLOOD, 2006, 108 (11) : 41A - 41A
  • [48] Eculizumab treatment in pregnant women with paroxysmal nocturnal hemoglobinuria: A Polish experience
    Czyz, Jaroslaw
    Szukalski, Lukasz
    Szukalska, Adriana
    Budziszewska, Bozena Katarzyna
    Lech-Maranda, Ewa
    Zdziarska, Joanna
    Sacha, Tomasz
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2022, 31 (06): : 707 - 710
  • [49] Hereditary Hemochromatosis Manifesting After Treatment of Paroxysmal Nocturnal Hemoglobinuria With Eculizumab
    Elliott, Elizabeth
    Waheed, Salman
    Syed, Sahr
    Eswaran, Sheila
    Gregory, Stephanie
    Shammo, Jamile
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (01): : E9 - E12
  • [50] Eculizumab Treatment Improves Outcomes of Pregnancy in Patients with Paroxysmal Nocturnal Hemoglobinuria
    Kelly, Richard J.
    Hoechsmann, Britta
    Kulasekararaj, Austin
    de Guibert, Sophie
    Roeth, Alexander
    Weitz, Ilene C.
    Armstrong, Elina
    Hill, Anita
    Risitano, Antonio M.
    Patriquin, Christopher J.
    Terriou, Louis
    Muus, Petra
    Turner, Michelle P.
    Schrezenmeier, Hubert
    Szer, Jeffrey
    de latour, Regis Peffault
    BLOOD, 2014, 124 (21)
12345